Innovations Spotlight

3rd Annual Cleveland Medical Hackathon Announces Winners

10/22/2017

3rd Annual Cleveland Medical Hackathon Announces Winners

Winners of the 24-hour innovation session included a smart wearable band for cardiology patients, a telehealth platform for populations without internet, and a navigation aid for the visually impaired.


MIS2017: What to Know Before you Go

10/21/2017

MIS2017: What to Know Before you Go

See you at the Summit!

Here are a few things to help you plan your trip to downtown Cleveland.


MIS2017 Panel Preview: Precision Medicine Policy: Can the Government Cure Cancer?

10/06/2017

MIS2017 Panel Preview: Precision Medicine Policy: Can the Government Cure Cancer?

One year has passed since Joe Biden urged MIS2016 attendees to act with the “urgency of now” in the global fight against cancer. He laid out the need for radical collaborations at the federal level that could enable data sharing, clinical trial redesign, the use of supercomputers, and precision medicine to take this fight to a new level. 


Dr. Gail Cresci weighs in on how colon cleaning affects gut microbiome

08/18/2017

Dr. Gail Cresci weighs in on how colon cleaning affects gut microbiome

In a recent New York Times article, Dr. Gail Cresci gave her opinion on how a colon cleanse affects the gut microbiome. The microbiome, which was ranked #1 in the Top 10 Medical Innovations for 2017, will be discussed in more detail at the 2017 Medical Innovation Summit.


MIS2017 Update: New Tracks & Speakers

08/17/2017

MIS2017 Update: New Tracks & Speakers

MIS2017 is just over two months away. See what's new inside!


Cleveland Clinic

08/16/2017

Cleveland Clinic's Preclinical R&D Facility - A Bridge to the Industry

Companies large and small are coming to Cleveland Clinic to leverage world class expertise, validate early-stage technologies, and conduct educational hands-on training. For eleven years, Cleveland Clinic Innovations’ Preclinical R&D Facility has been busy proving a theory: Combining top-notch minds with state-of-the-art resources will create an alchemy of innovation.
 


MIS2017 Panel Preview - State of Healthcare Innovation: A Pharma Perspective

08/15/2017

MIS2017 Panel Preview - State of Healthcare Innovation: A Pharma Perspective

When it comes to drug pricing, healthcare is still in gridlock. While hospitals are working to streamline care and remove costs, the drug industry is putting higher and higher prices on their medications. Pharma companies contend that they are simply accounting for the tremendous resources invested in R&D. Providers, of course, want to prescribe the best treatment for their patients, regardless of price. Yet, insurance companies and formulary companies are hesitant, and often unable, to pay the exorbitant prices.
 


DBS for Stroke Recovery: First Patient’s Early Results Exceed Expectations

08/14/2017

DBS for Stroke Recovery: First Patient’s Early Results Exceed Expectations

In late 2016, Dr. Andre Machado performed the world's first DBS procedure for stroke recovery. Almost nine months after her initial surgery and four months after turning the device on, the patient is seeing continued function and improvement in her previously paralyzed arm.


TMAO-Producing Enzyme Shown to Regulate Obesity in Humans

08/01/2017

TMAO-Producing Enzyme Shown to Regulate Obesity in Humans

New research from Stan Hazen, MD, PhD, has shown that TMAO-producing enzyme has been shown to regulate obesity in humans. This research, as well as a deeper dive into the microbiome, will be discussed at the 2017 Medical Innovation Summit. 


MIS2017 Panel Preview: Destiny Changing Technologies: Making Sense of Gene Therapy, Gene Silencing, and Gene Editing Markets

07/26/2017

MIS2017 Panel Preview: Destiny Changing Technologies: Making Sense of Gene Therapy, Gene Silencing, and Gene Editing Markets

With the recent recommendation to approve a new gene therapy aimed at leukemia and lymphoma, the national media is buzzing about what this means for a host of other diseases and technologies. It wasn’t long ago that “gene therapy” represented the flaws and dangers of re-engineering genes and immune systems to fight disease. Throughout its hiatus, researchers have been working on a host of safer, more effective techniques resulting in potential treatments for blindness, hemophelia, and CALD.


 <  3 4 5 6 7 8 9 10 11 12  > 

Get In Touch With Us